Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts

Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts

Background: Mucinous adenocarcinoma is a frequent subtype in colorectal cancer (CRC). A higher initial T-stage, poorer differentiation, worse response to anti-tumor therapies, and shorter survival are characteristic of mucinous CRC. Moreover, the therapeutic benefit of cytoreductive surgery with hyp...

Full description

Bibliographic Details
Main Authors: Zoltan Herold, Miklos Acs, Attila Marcell Szasz, Katalin Olasz, Jana Hussong, Max Mayr, Magdolna Dank, Pompiliu Piso
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
colorectal neoplasms
cytoreductive surgery
HIPEC
mucinous carcinoma
adenocarcinoma
Online Access:https://www.mdpi.com/2072-6694/14/16/3978

Internet

https://www.mdpi.com/2072-6694/14/16/3978

Similar Items